However, IDH‐mutated GB are now considered to be IDH‐mutated grade 4 astrocytomas, with gene methylation and expression profiles different from those of IDH‐wild‐type GB, and a different prognosis and response to treatment [8, 9]. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).